IDEX Biometrics is expanding its presence in Asia with Beautiful Card Corporation (BCC), one of the top 10 smart card manufacturers globally. BCC will ramp production of the IDEX Pay Biometric card solution in response to increasing demand from issuers and banks in the region.
Save time and jump to the most important pieces.
15F-12B - IDEX Biometrics ASA (0001824036) (Filer)
6-K - IDEX Biometrics ASA (0001824036) (Filer)
25 - IDEX Biometrics ASA (0001824036) (Filer)
IDEX Biometrics ASA will hold an extraordinary general meeting on Thursday 21 December 2023 at 12.00 hours CET as an online meeting. There is no physical attendance option. Shareholders may attend online. by PC, smartphone or tablet. The notice with attendance form will be sent to the shareholders today and is also enclosed in pdf file (links to notice, bilingual, and attendance form, English and Norwegian, below). The extraordinary general meeting will consider and resolve Share consolidationIssuance of convertible loan (ref notice to the market on 7 November 2023)Renewal of the customary authorizations to the board to issue sharesAmendment of the 2023 subscription rights incentive p
Reference is made to the notice on 15 November 2023 regarding private placement of 78,651,685 shares at NOK 0.445 per share. The capital increase has been registered and the shares will be delivered soonest. Following the issue, the company's share capital is NOK 209,493,156.- divided into 1,396,621,040 shares, each with a nominal value of NOK 0.15. For further information contact:Marianne Bøe, Investor RelationsE-mail: [email protected]: +47 918 00186 About IDEX BiometricsIDEX Biometrics (NASDAQ:IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal authentication for all. We help people make payments, prove their
Reference is made to the notice on 1 September 2023 regarding employees acquiring shares under IDEX Biometrics 2022 Employee Share Purchase Plan. The capital increase, 1,935,611 shares, has been registered and the shares issued. Following the issue, the company's share capital is NOK 197,695,403.25 divided into 1,317,969,355 shares, each with a nominal value of NOK 0.15. For further information contact:Marianne Bøe, Investor RelationsE-mail: [email protected]: +47 918 00186 About IDEX BiometricsIDEX Biometrics (NASDAQ:IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal authentication for all. We help people make
IDEX Biometrics ASA ("IDEX" or the "Company") (NASDAQ:IDBA) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control and digital identity. The Company's voluntary delisting of American Depositary Shares ("ADSs") representing its ordinary shares from The Nasdaq Capital Market ("Nasdaq") has become effective. Each ADS represents 75 ordinary shares of the Company. The Company has also filed a Form 15 with the Securities and Exchange Commission ("SEC") to suspend its reporting obligations under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), in respect of the ADSs and the ordinary shares. The Company expects
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. • Caledonia Mining (AMEX:CMCL) is estimated to report earnings for its second quarter. • Novo Nordisk (NYSE:NVO) is estimated to report quarterly earnings at $1.28 per share on revenue of $7.97 billion. • Addex Therapeutics (NASDAQ:ADXN) is expected to report earnings for its second quarter. • ProFrac Holding (NASDAQ:ACDC) is likely to report quarterly earnings at $0.27 per share on revenue of $751.21 million. • Kelly Services (NASDAQ:KELYB) is estimated to report earnings for its second quarter. • Mogo (NASDAQ:MOGO) is estimated to
IDEX Biometrics (NASDAQ:IDBA) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.39) by 97.44 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.46 million which missed the analyst consensus estimate of $1.60 million by 8.56 percent. This is a 32.04 percent increase over sales of $1.11 million the same period last year.